VERO Stock Summary and Trading Ideas (Venus Concept | NASDAQ:VERO)

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Venus Concept trades on the NASDAQ stock market under the symbol VERO.

As of April 24, 2024, VERO stock price declined to $0.72 with 7,790 million shares trading.

VERO has a beta of -1.88, meaning it tends to be less sensitive to market movements. VERO has a correlation of 0.04 to the broad based SPY ETF.

VERO has a market cap of $4.58 million. This is considered a Sub-Micro Cap stock.

Last quarter Venus Concept reported $18 million in Revenue and -$2.01 earnings per share. This fell short of revenue expectation by $-4 million and missed earnings estimates by -$.83.

In the last 3 years, VERO stock traded as high as $50.55 and as low as $.60.

The top ETF exchange traded funds that VERO belongs to (by Net Assets): VXF.

VERO has underperformed the market in the last year with a return of -74.5%, while the SPY ETF gained +24.1%. In the last 3 month period, VERO fell short of the market, returning -39.9%, while SPY returned +4.5%. However, in the most recent 2 weeks VERO has outperformed the stock market by returning +4.5%, while SPY returned -1.7%.

VERO support price is $.69 and resistance is $.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VERO stock will trade within this expected range on the day.